about
Insight into Best Variables for COPD Case Identification: A Random Forests AnalysisIdentifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies.Visual Assessment of CT Findings in Smokers With Nonobstructed Spirometric Abnormalities in The COPDGene(®) StudyRepeatability and Sample Size Assessment Associated with Computed Tomography-Based Lung Density Metrics.Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD.Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary DiseaseAbdominal Visceral Adipose Tissue is Associated with Myocardial Infarction in Patients with COPD.Integrating COPD into Patient-Centered Hospital Readmissions Reduction ProgramsPHYSIOLOGIC AND QUANTITATIVE COMPUTED TOMOGRAPHY DIFFERENCES BETWEEN CENTRILOBULAR AND PANLOBULAR EMPHYSEMA IN COPD.Can Commercially Available Pedometers Be Used For Physical Activity Monitoring In Patients With COPD Following Exacerbations?Pulmonary Predictors of Incident Diabetes in Smokers.Identification of Barriers to Influenza Vaccination in Patients with Chronic Obstructive Pulmonary Disease: Analysis of the 2012 Behavioral Risk Factors Surveillance System.Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study.Prevalence of Low Peak Inspiratory Flow Rate at Discharge in Patients Hospitalized for COPD ExacerbationThe 2017 Update to the COPD Foundation COPD Pocket Consultant Guide.Socioeconomic Status as a Determinant of Health Status Treatment Response in COPD Trials.Baseline Severity as Predictor of Change in St George's Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients.Responder Analyses for Treatment Effects in COPD Using the St George's Respiratory Questionnaire.The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George's Respiratory Questionnaire Dataset.Subtyping Chronic Obstructive Pulmonary Disease Using Peripheral Blood Proteomics.Asthma and Chronic Obstructive Pulmonary Disease Overlap: The Effect of Definitions on Measures of Burden.Benefits Among Patients with Alpha-1 Antitrypsin Deficiency Enrolled in a Disease Management and Prevention ProgramThe Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension Trials.Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging StudyEfficacy of Indacaterol/Glycopyrronium in Patients with COPD Who Have Increased Dyspnea with Daily Activities.Identifying Patients With COPD at High Risk of Readmission.Panlobular Emphysema: Enhancing Visibility with Quantitative Computed Tomography.The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.Health Status of Patients With Chronic Obstructive Pulmonary Disease by Symptom LevelPrimary Care Physicians', Nurse Practitioners' and Physician Assistants' Knowledge, Attitudes and Beliefs Regarding COPD: 2007 To 2014.High-Dose Versus Low-Dose Systemic Steroids in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Systematic ReviewEfficacy and Safety of Twice-Daily Glycopyrrolate Versus Placebo in Patients With COPD: The GEM2 Study.Characteristics of COPD Patients Using United States Emergency Care or HospitalizationRelationship Between FEV1 and Patient-Reported Outcomes Changes: Results of a Meta-Analysis of Randomized Trials in Stable COPD.The Human Microbiome in the Lung: Are Infections Contributing to Lung Health and Disease?Overall and Cardiovascular Safety of Aclidinium Bromide in Patients With COPD: A Pooled Analysis of Six Phase III, Placebo-Controlled, Randomized StudiesAmbulatory Oxygen for Exercise-Induced Desaturation and Dyspnea in Chronic Obstructive Pulmonary Disease (COPD): Systematic Review and Meta-Analysis.Daily Peak Expiratory Flow Rate and Disease Instability in Chronic Obstructive Pulmonary Disease.Systematic Review of the Association Between Laboratory- and Field-Based Exercise Tests and Lung Function in Patients with Chronic Obstructive Pulmonary Disease
P1433
Q30361262-6175BF57-764F-453E-B949-A08E1B2B5CE5Q30371730-38AA9D90-0A2E-433E-BFE8-09A0A2677B41Q34129125-7327E5D4-C483-44B1-888A-4D22F34F093CQ34781825-9E82F987-6376-4559-B52D-ECEB7C9838D8Q35077912-2028BFBC-5057-4508-8372-937FBD9CF16EQ35087187-C24466AF-5C52-4867-8C2B-9B3E53DA2234Q35241498-892DB0F0-EB29-4881-BA5A-57D8F167D28DQ35533910-1F239838-0F34-487D-B682-3C3C9049EEE8Q35541274-2729C14A-28C2-4A14-A890-61F512757B38Q35659735-F5B6310F-3E26-4B7D-96FA-265FBE2C7F27Q37186773-81234965-B714-43DD-9498-B7EAC1C5AB8FQ37375728-37AE4B17-42C2-4F6E-B899-694E5C50CE7FQ37499941-1F7BA08A-C876-4794-B0A0-80FD287C2CFFQ38371555-81DC6C1F-A8DA-4F14-B557-FD1F3D9B7EE0Q38604589-35D68C32-4E0C-4602-B291-65149B2CBDFEQ38604593-8B2BA25E-F52E-4EE7-9783-D380A19ECFA2Q38604595-B5A1CFE3-122B-4983-8E45-F7F8F0B37D3FQ38604599-150D437D-8A4D-4069-AFA2-3DB3D2ADD49AQ38604602-D72C1F2B-445D-4B33-9B30-7AD587F30311Q38604605-0635E756-80DF-4CEC-81F3-303462F83BCFQ38604607-B9BF882C-DDC6-4686-A51F-3D01CAFB1212Q38604609-9A69B802-9598-4E20-BA35-C2C4A4E340B1Q38604612-4C38C164-293D-411D-8C7E-6B854F8AB60CQ38604616-00030AD5-DA20-4EFD-BF8F-F7D9A7AA59A4Q38604619-21FB8F7E-135A-4E82-AE80-0A652E69B2BAQ38604621-D2E72064-AB3A-4C4B-B1D1-26642C26D852Q38604624-B330E5A7-6114-4634-8838-CC166139E830Q38604627-4474B79D-B8F0-41B9-9926-A7258733A939Q38604630-C25D8983-4766-496F-B592-46F5E7ACAF67Q38604633-7A8E43C1-8AE5-403C-9EC5-FD40F7BB166BQ38604636-F1F3E0B4-05A9-4D86-9783-FA6F08F60AEAQ38604638-D9798236-10AF-47BD-B5AD-D595857C68F6Q38604641-2EE0E474-8A67-4B1E-BA68-F9C01DA3B412Q38604642-E3F6F096-1F55-42AA-8130-7D07424FEC6CQ38604644-356E84A6-09A7-4088-BB9D-18E29D565164Q38604647-2AB65F58-0150-4F3F-AFCC-7FA7EFE04001Q38604650-82D8A56A-CE1F-4D04-9220-7FD6612E948CQ38604652-88246B80-D50E-41E1-8BAC-B3966FE45CDCQ38604654-0FA51080-E4C1-4576-8E0F-3D00175C0EEFQ38604656-B84B71BA-CD3A-4E8C-AE0E-1A1D5CA673E8
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Chronic obstructive pulmonary diseases (Miami, Fla.)
@ast
Chronic obstructive pulmonary diseases (Miami, Fla.)
@en
Chronic obstructive pulmonary diseases (Miami, Fla.)
@es
Chronic obstructive pulmonary diseases (Miami, Fla.)
@nl
type
label
Chronic obstructive pulmonary diseases (Miami, Fla.)
@ast
Chronic obstructive pulmonary diseases (Miami, Fla.)
@en
Chronic obstructive pulmonary diseases (Miami, Fla.)
@es
Chronic obstructive pulmonary diseases (Miami, Fla.)
@nl
altLabel
Chronic Obstr Pulm Dis
@en
prefLabel
Chronic obstructive pulmonary diseases (Miami, Fla.)
@ast
Chronic obstructive pulmonary diseases (Miami, Fla.)
@en
Chronic obstructive pulmonary diseases (Miami, Fla.)
@es
Chronic obstructive pulmonary diseases (Miami, Fla.)
@nl
P31
P3181
P1055
P1156
21100870389
P123
P127
P1476
Chronic obstructive pulmonary diseases (Miami, Fla.)
@en